

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 6.63635468 |
| 2 | lysine catabolic process (GO:0006554) | 6.63635468 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.38787087 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.38787087 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.19867308 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.19827548 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.19827548 |
| 8 | cysteine metabolic process (GO:0006534) | 6.01214437 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.93933815 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.93933815 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.93933815 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.91055190 |
| 13 | urate metabolic process (GO:0046415) | 5.87634350 |
| 14 | drug transmembrane transport (GO:0006855) | 5.70238012 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.60800091 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.58076519 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.37714373 |
| 18 | homocysteine metabolic process (GO:0050667) | 5.17702026 |
| 19 | amino-acid betaine metabolic process (GO:0006577) | 5.09665447 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.95644860 |
| 21 | drug transport (GO:0015893) | 4.95503534 |
| 22 | drug catabolic process (GO:0042737) | 4.94801931 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.83288919 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.83250152 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.83065307 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.82924693 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 4.75797403 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.60952725 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 4.58969504 |
| 30 | short-chain fatty acid metabolic process (GO:0046459) | 4.57422740 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.57034505 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.57034505 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 4.57034505 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 4.57034505 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 4.57034505 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.57034505 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.51498301 |
| 38 | urea cycle (GO:0000050) | 4.51034344 |
| 39 | urea metabolic process (GO:0019627) | 4.51034344 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.36398689 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 4.35912695 |
| 42 | glutamate metabolic process (GO:0006536) | 4.35393053 |
| 43 | response to peptidoglycan (GO:0032494) | 4.35069516 |
| 44 | carnitine metabolic process (GO:0009437) | 4.34809485 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 4.30665385 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 4.29829588 |
| 47 | fatty acid beta-oxidation (GO:0006635) | 4.28511813 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 4.24639703 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 4.20355845 |
| 50 | exogenous drug catabolic process (GO:0042738) | 4.19096448 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.17764613 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 4.17610940 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.17065265 |
| 54 | fatty acid oxidation (GO:0019395) | 4.12235384 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.11234557 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.10708303 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 4.09347471 |
| 58 | bile acid metabolic process (GO:0008206) | 4.08763923 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.08587860 |
| 60 | amine catabolic process (GO:0009310) | 4.08587860 |
| 61 | lipid oxidation (GO:0034440) | 4.07786174 |
| 62 | valine metabolic process (GO:0006573) | 4.04780702 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 4.02159447 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 3.99050450 |
| 65 | ketone body metabolic process (GO:1902224) | 3.98446780 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.98420318 |
| 67 | organic cation transport (GO:0015695) | 3.93741002 |
| 68 | negative regulation of cell killing (GO:0031342) | 3.92964633 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92964633 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.90033179 |
| 71 | fatty acid catabolic process (GO:0009062) | 3.89491123 |
| 72 | tyrosine metabolic process (GO:0006570) | 3.86842136 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.85079394 |
| 74 | organic acid catabolic process (GO:0016054) | 3.84487774 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.84487774 |
| 76 | response to mercury ion (GO:0046689) | 3.83201531 |
| 77 | detection of other organism (GO:0098543) | 3.82979231 |
| 78 | monocarboxylic acid catabolic process (GO:0072329) | 3.81720928 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.80827378 |
| 80 | branched-chain amino acid metabolic process (GO:0009081) | 3.80021509 |
| 81 | negative regulation of sterol transport (GO:0032372) | 3.79630653 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.79630653 |
| 83 | phosphate ion transport (GO:0006817) | 3.79317250 |
| 84 | cellular extravasation (GO:0045123) | 3.78859386 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78034365 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77956425 |
| 87 | quaternary ammonium group transport (GO:0015697) | 3.77452060 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.75350223 |
| 89 | cellular glucuronidation (GO:0052695) | 3.75184769 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.71810307 |
| 91 | ethanol oxidation (GO:0006069) | 3.71482944 |
| 92 | phosphate ion transmembrane transport (GO:0035435) | 3.71443775 |
| 93 | complement activation, alternative pathway (GO:0006957) | 3.71343450 |
| 94 | branched-chain amino acid catabolic process (GO:0009083) | 3.67491167 |
| 95 | protein carboxylation (GO:0018214) | 3.67254258 |
| 96 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.67254258 |
| 97 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.67232605 |
| 98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.65251856 |
| 99 | acylglycerol homeostasis (GO:0055090) | 3.60336493 |
| 100 | triglyceride homeostasis (GO:0070328) | 3.60336493 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.59482334 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 3.59482334 |
| 103 | macromolecular complex remodeling (GO:0034367) | 3.59482334 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.59426267 |
| 105 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58984128 |
| 106 | coenzyme catabolic process (GO:0009109) | 3.58409693 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.58332068 |
| 108 | reverse cholesterol transport (GO:0043691) | 3.57314703 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.56705516 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.56705516 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 3.56420263 |
| 112 | fructose metabolic process (GO:0006000) | 3.56367257 |
| 113 | immunoglobulin mediated immune response (GO:0016064) | 3.53121956 |
| 114 | regulation of protein activation cascade (GO:2000257) | 3.52652295 |
| 115 | negative regulation of fibrinolysis (GO:0051918) | 3.50824400 |
| 116 | amino-acid betaine transport (GO:0015838) | 3.49048792 |
| 117 | carnitine transport (GO:0015879) | 3.49048792 |
| 118 | response to phenylpropanoid (GO:0080184) | 3.45386924 |
| 119 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43981197 |
| 120 | phospholipid efflux (GO:0033700) | 3.43222807 |
| 121 | glycine metabolic process (GO:0006544) | 3.43093477 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42820976 |
| 123 | drug metabolic process (GO:0017144) | 3.41717004 |
| 124 | detection of biotic stimulus (GO:0009595) | 3.41624917 |
| 125 | phospholipid homeostasis (GO:0055091) | 3.41584216 |
| 126 | biotin metabolic process (GO:0006768) | 3.40403034 |
| 127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40370207 |
| 128 | detection of bacterium (GO:0016045) | 3.36993936 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34683032 |
| 130 | microglial cell activation (GO:0001774) | 3.28861281 |
| 131 | plasma lipoprotein particle assembly (GO:0034377) | 3.27284286 |
| 132 | macrophage activation (GO:0042116) | 3.21074455 |
| 133 | low-density lipoprotein particle remodeling (GO:0034374) | 3.19224885 |
| 134 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17890849 |
| 135 | T-helper 1 type immune response (GO:0042088) | 3.14883026 |
| 136 | germinal center formation (GO:0002467) | 3.10357008 |
| 137 | angiotensin maturation (GO:0002003) | 3.06391311 |
| 138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04501664 |
| 139 | response to host immune response (GO:0052572) | 3.04501664 |
| 140 | regulation of interferon-alpha production (GO:0032647) | 3.03794314 |
| 141 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03450166 |
| 142 | type I interferon signaling pathway (GO:0060337) | 3.03080987 |
| 143 | cellular response to type I interferon (GO:0071357) | 3.03080987 |
| 144 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02599113 |
| 145 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02456774 |
| 146 | neutrophil activation (GO:0042119) | 2.99338495 |
| 147 | response to type I interferon (GO:0034340) | 2.98910531 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.97901244 |
| 149 | positive regulation of interferon-alpha production (GO:0032727) | 2.97407070 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97224332 |
| 151 | positive regulation of type 2 immune response (GO:0002830) | 2.96626764 |
| 152 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94763728 |
| 153 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94257221 |
| 154 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.93994172 |
| 155 | B cell mediated immunity (GO:0019724) | 2.93587003 |
| 156 | granulocyte activation (GO:0036230) | 2.93456636 |
| 157 | defense response to protozoan (GO:0042832) | 2.91120256 |
| 158 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90429540 |
| 159 | regulation of tolerance induction (GO:0002643) | 2.89579751 |
| 160 | regulation of vitamin metabolic process (GO:0030656) | 2.85785838 |
| 161 | respiratory burst (GO:0045730) | 2.85564121 |
| 162 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84556295 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82001937 |
| 164 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81743535 |
| 165 | glycosphingolipid catabolic process (GO:0046479) | 2.79470012 |
| 166 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.79360380 |
| 167 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.77580415 |
| 168 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77474606 |
| 169 | response to host (GO:0075136) | 2.77355949 |
| 170 | response to host defenses (GO:0052200) | 2.77355949 |
| 171 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77355949 |
| 172 | regulation of T cell tolerance induction (GO:0002664) | 2.77164465 |
| 173 | response to interleukin-15 (GO:0070672) | 2.74280001 |
| 174 | myeloid dendritic cell differentiation (GO:0043011) | 2.70418261 |
| 175 | neutrophil mediated immunity (GO:0002446) | 2.69876907 |
| 176 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69609278 |
| 177 | regulation of mast cell degranulation (GO:0043304) | 2.69237294 |
| 178 | myeloid cell activation involved in immune response (GO:0002275) | 2.68140311 |
| 179 | negative regulation of protein activation cascade (GO:2000258) | 2.66869670 |
| 180 | response to protozoan (GO:0001562) | 2.66373758 |
| 181 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65984630 |
| 182 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65426091 |
| 183 | positive regulation of tolerance induction (GO:0002645) | 2.64848066 |
| 184 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.64354285 |
| 185 | positive regulation of acute inflammatory response (GO:0002675) | 2.62832660 |
| 186 | regulation of podosome assembly (GO:0071801) | 2.61654998 |
| 187 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61277859 |
| 188 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59665511 |
| 189 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58727689 |
| 190 | leukocyte aggregation (GO:0070486) | 2.57573251 |
| 191 | negative regulation of complement activation (GO:0045916) | 2.57146465 |
| 192 | cholesterol efflux (GO:0033344) | 2.56982962 |
| 193 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56328200 |
| 194 | glycolipid catabolic process (GO:0019377) | 2.55400131 |
| 195 | peptide catabolic process (GO:0043171) | 2.54272345 |
| 196 | negative regulation of humoral immune response (GO:0002921) | 2.54260627 |
| 197 | oligosaccharide catabolic process (GO:0009313) | 2.53339547 |
| 198 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.52588279 |
| 199 | dendritic cell chemotaxis (GO:0002407) | 2.52108164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.32541591 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.24647200 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77309870 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.59319661 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.43792548 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33345562 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03738752 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90148664 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.75172824 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48710551 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24481478 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96497511 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95055105 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92318805 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82741453 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73824150 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50607017 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.32160926 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21558413 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17998095 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14167782 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02495721 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0963589 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99249469 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97274225 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96029538 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89656466 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87584336 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74058705 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73161576 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72609304 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72075306 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.67192274 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63260958 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62974095 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57030391 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56108534 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54431452 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52595564 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51603248 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51229492 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51203795 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48379228 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.48194800 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48028535 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47155461 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45675997 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45244653 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43973728 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43909933 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42002984 |
| 52 | * MYB_26560356_Chip-Seq_TH1_Human | 1.41535797 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.40851057 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40448336 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35818566 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31791523 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29002419 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28921577 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27574900 |
| 60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26926177 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26177747 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.26129681 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25971946 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25525472 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23968787 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21507083 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20895719 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20843299 |
| 69 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.19773565 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16864578 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16072988 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14330002 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13623834 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12620752 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11150455 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08421407 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06907381 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06647817 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04326495 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04186832 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00720962 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00716271 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99552193 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97357096 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96803439 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96803439 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96217239 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95493712 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94647856 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94542651 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93990931 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93529050 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92702083 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92038886 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91107503 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89447637 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87561041 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86507905 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85702840 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85192179 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84996673 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84874513 |
| 103 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84258083 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83017324 |
| 105 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.79629552 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79585541 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79332300 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78050143 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77954445 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72926948 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71063655 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70629434 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.69956519 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.69845129 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69825823 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69758329 |
| 117 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68412371 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67092183 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.66469390 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66423304 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66009991 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.65575690 |
| 123 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.64597070 |
| 124 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63280816 |
| 125 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63110033 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62437651 |
| 127 | VDR_22108803_ChIP-Seq_LS180_Human | 0.62082008 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61988538 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61839238 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61050432 |
| 131 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.60675585 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60636115 |
| 133 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.59438661 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.59413994 |
| 135 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.59191080 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.58516163 |
| 137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.57968953 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57912948 |
| 139 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.57718304 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.56308222 |
| 141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55994207 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.55692002 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.55686879 |
| 144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55583550 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.55424181 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.54384196 |
| 147 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.53761540 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53262854 |
| 149 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50082739 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48954664 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48921133 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48720163 |
| 153 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.48181724 |
| 154 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.48134457 |
| 155 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.48134457 |
| 156 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.47996389 |
| 157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.47844133 |
| 158 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.47416670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.40999599 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.19223127 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18129657 |
| 4 | MP0005365_abnormal_bile_salt | 4.95108441 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.54202936 |
| 6 | MP0003303_peritoneal_inflammation | 4.23039437 |
| 7 | MP0005332_abnormal_amino_acid | 3.82429220 |
| 8 | MP0003195_calcinosis | 3.59998059 |
| 9 | MP0003252_abnormal_bile_duct | 3.50604874 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.33593204 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.26404768 |
| 12 | MP0001835_abnormal_antigen_presentation | 3.15484592 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.99208109 |
| 14 | MP0009785_altered_susceptibility_to | 2.95024472 |
| 15 | MP0004043_abnormal_pH_regulation | 2.61414362 |
| 16 | MP0002419_abnormal_innate_immunity | 2.58482411 |
| 17 | MP0009840_abnormal_foam_cell | 2.53559572 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.51145396 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.47312394 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.44292291 |
| 21 | MP0005025_abnormal_response_to | 2.43206143 |
| 22 | MP0001790_abnormal_immune_system | 2.39739310 |
| 23 | MP0005387_immune_system_phenotype | 2.39739310 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.35589238 |
| 25 | MP0009643_abnormal_urine_homeostasis | 2.28248744 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.23059386 |
| 27 | MP0000685_abnormal_immune_system | 2.18571247 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.15285963 |
| 29 | MP0001800_abnormal_humoral_immune | 2.13196304 |
| 30 | MP0005083_abnormal_biliary_tract | 2.09115646 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.07876593 |
| 32 | MP0005671_abnormal_response_to | 2.05728806 |
| 33 | MP0002723_abnormal_immune_serum | 2.01654245 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.98382937 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.93614819 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.90604203 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.83598503 |
| 38 | MP0008260_abnormal_autophagy | 1.83436428 |
| 39 | MP0000609_abnormal_liver_physiology | 1.80713890 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.78612795 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.74229723 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.74043954 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.71314452 |
| 44 | MP0001819_abnormal_immune_cell | 1.71049481 |
| 45 | MP0005451_abnormal_body_composition | 1.66662549 |
| 46 | MP0003186_abnormal_redox_activity | 1.65843894 |
| 47 | MP0004947_skin_inflammation | 1.63751560 |
| 48 | MP0001764_abnormal_homeostasis | 1.62530170 |
| 49 | MP0002405_respiratory_system_inflammati | 1.61040306 |
| 50 | MP0008004_abnormal_stomach_pH | 1.59810249 |
| 51 | MP0006054_spinal_hemorrhage | 1.58584933 |
| 52 | MP0001756_abnormal_urination | 1.56477870 |
| 53 | MP0002132_abnormal_respiratory_system | 1.49875454 |
| 54 | MP0001765_abnormal_ion_homeostasis | 1.48797838 |
| 55 | MP0005164_abnormal_response_to | 1.46103039 |
| 56 | MP0002136_abnormal_kidney_physiology | 1.44378722 |
| 57 | MP0000858_altered_metastatic_potential | 1.41046024 |
| 58 | MP0004883_abnormal_blood_vessel | 1.39127313 |
| 59 | MP0005310_abnormal_salivary_gland | 1.37573711 |
| 60 | MP0004510_myositis | 1.34848640 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.32236824 |
| 62 | MP0000343_altered_response_to | 1.29642951 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.28298772 |
| 64 | MP0003866_abnormal_defecation | 1.27604232 |
| 65 | MP0005670_abnormal_white_adipose | 1.25205683 |
| 66 | MP0000716_abnormal_immune_system | 1.24655032 |
| 67 | MP0009764_decreased_sensitivity_to | 1.22692740 |
| 68 | MP0003868_abnormal_feces_composition | 1.20039931 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.19436631 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.18399629 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.17396536 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.17396536 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.17284320 |
| 74 | MP0005535_abnormal_body_temperature | 1.14011780 |
| 75 | MP0009278_abnormal_bone_marrow | 1.13036326 |
| 76 | MP0002398_abnormal_bone_marrow | 1.10354841 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.09997970 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.07386577 |
| 79 | MP0003448_altered_tumor_morphology | 1.04987791 |
| 80 | MP0000604_amyloidosis | 1.04713198 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.04557923 |
| 82 | MP0003828_pulmonary_edema | 1.00487235 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.99370804 |
| 84 | MP0002429_abnormal_blood_cell | 0.97510095 |
| 85 | MP0009697_abnormal_copulation | 0.97115566 |
| 86 | MP0003878_abnormal_ear_physiology | 0.96104993 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.96104993 |
| 88 | MP0000598_abnormal_liver_morphology | 0.95664571 |
| 89 | MP0008469_abnormal_protein_level | 0.95345752 |
| 90 | MP0002722_abnormal_immune_system | 0.93958997 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.91608048 |
| 92 | MP0002971_abnormal_brown_adipose | 0.90616471 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.89127239 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.86360391 |
| 95 | MP0002254_reproductive_system_inflammat | 0.85383824 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.85174996 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.84756284 |
| 98 | MP0000249_abnormal_blood_vessel | 0.84616305 |
| 99 | MP0004130_abnormal_muscle_cell | 0.84320743 |
| 100 | MP0001663_abnormal_digestive_system | 0.82440612 |
| 101 | MP0003011_delayed_dark_adaptation | 0.80648061 |
| 102 | MP0009763_increased_sensitivity_to | 0.80390407 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.80153003 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.79935062 |
| 105 | MP0003724_increased_susceptibility_to | 0.79619770 |
| 106 | MP0003763_abnormal_thymus_physiology | 0.78474519 |
| 107 | MP0003690_abnormal_glial_cell | 0.77801848 |
| 108 | MP0005647_abnormal_sex_gland | 0.77764476 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.77256962 |
| 110 | MP0002006_tumorigenesis | 0.75255581 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.73496038 |
| 112 | MP0001851_eye_inflammation | 0.73044930 |
| 113 | MP0005408_hypopigmentation | 0.72771072 |
| 114 | MP0003646_muscle_fatigue | 0.71716941 |
| 115 | MP0003705_abnormal_hypodermis_morpholog | 0.71326894 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.71149111 |
| 117 | MP0005409_darkened_coat_color | 0.70843806 |
| 118 | MP0000920_abnormal_myelination | 0.69074199 |
| 119 | MP0002168_other_aberrant_phenotype | 0.68059957 |
| 120 | MP0004147_increased_porphyrin_level | 0.67886886 |
| 121 | MP0001661_extended_life_span | 0.67174813 |
| 122 | MP0005395_other_phenotype | 0.67120405 |
| 123 | MP0003075_altered_response_to | 0.66037806 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.65130749 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.64550658 |
| 126 | MP0003329_amyloid_beta_deposits | 0.64113087 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.64005704 |
| 128 | MP0005334_abnormal_fat_pad | 0.63787354 |
| 129 | MP0002933_joint_inflammation | 0.63002506 |
| 130 | MP0000569_abnormal_digit_pigmentation | 0.62637521 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.61443115 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.60980621 |
| 133 | MP0005166_decreased_susceptibility_to | 0.59565812 |
| 134 | MP0005266_abnormal_metabolism | 0.59336021 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.58092797 |
| 136 | MP0001881_abnormal_mammary_gland | 0.57838953 |
| 137 | MP0002928_abnormal_bile_duct | 0.57136852 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.56720152 |
| 139 | MP0001958_emphysema | 0.56329124 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.55738056 |
| 141 | MP0002135_abnormal_kidney_morphology | 0.52691469 |
| 142 | MP0002796_impaired_skin_barrier | 0.49122683 |
| 143 | MP0003718_maternal_effect | 0.47761440 |
| 144 | MP0003953_abnormal_hormone_level | 0.47522818 |
| 145 | MP0009115_abnormal_fat_cell | 0.47400334 |
| 146 | MP0006082_CNS_inflammation | 0.47158682 |
| 147 | MP0005220_abnormal_exocrine_pancreas | 0.45003954 |
| 148 | MP0004782_abnormal_surfactant_physiolog | 0.44072100 |
| 149 | MP0003436_decreased_susceptibility_to | 0.44066337 |
| 150 | MP0005448_abnormal_energy_balance | 0.44002769 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.43963146 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.41470787 |
| 153 | MP0008872_abnormal_physiological_respon | 0.39766660 |
| 154 | MP0008874_decreased_physiological_sensi | 0.39298657 |
| 155 | MP0002837_dystrophic_cardiac_calcinosis | 0.37317256 |
| 156 | MP0004885_abnormal_endolymph | 0.34989330 |
| 157 | MP0001853_heart_inflammation | 0.33499545 |
| 158 | MP0005165_increased_susceptibility_to | 0.33041809 |
| 159 | MP0008873_increased_physiological_sensi | 0.32561999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.53924216 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.47357304 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.32139175 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.29428803 |
| 5 | Orchitis (HP:0100796) | 5.12455229 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.03158591 |
| 7 | Optic neuritis (HP:0100653) | 5.03158591 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.95657190 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.93654820 |
| 10 | Gout (HP:0001997) | 4.91768892 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.88596016 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.88596016 |
| 13 | Xanthomatosis (HP:0000991) | 4.81415296 |
| 14 | Myositis (HP:0100614) | 4.73898310 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.73182774 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.65996416 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.59267699 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.47690998 |
| 19 | Deep venous thrombosis (HP:0002625) | 4.45329267 |
| 20 | Hyperammonemia (HP:0001987) | 4.44000782 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.29576705 |
| 22 | Hyperglycinemia (HP:0002154) | 4.20345844 |
| 23 | * Ketosis (HP:0001946) | 4.17542128 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 4.14179059 |
| 25 | Proximal tubulopathy (HP:0000114) | 4.10159966 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.08208287 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 4.05336578 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.88071677 |
| 29 | Hypokalemic alkalosis (HP:0001949) | 3.85420194 |
| 30 | Increased circulating renin level (HP:0000848) | 3.81350294 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.78424985 |
| 32 | Metabolic alkalosis (HP:0200114) | 3.78247849 |
| 33 | Gingival bleeding (HP:0000225) | 3.75040436 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.74839336 |
| 35 | Increased purine levels (HP:0004368) | 3.70172348 |
| 36 | Hyperuricemia (HP:0002149) | 3.70172348 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.69403033 |
| 38 | Hyperactive renin-angiotensin system (HP:0000841) | 3.67732650 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 3.59143256 |
| 40 | Stomatitis (HP:0010280) | 3.58923581 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 3.58414021 |
| 42 | Alkalosis (HP:0001948) | 3.54616006 |
| 43 | * Ketoacidosis (HP:0001993) | 3.54039004 |
| 44 | Hypoglycemic coma (HP:0001325) | 3.49522342 |
| 45 | Generalized aminoaciduria (HP:0002909) | 3.36873371 |
| 46 | Hypomagnesemia (HP:0002917) | 3.36299084 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 3.34688151 |
| 48 | Abnormal urine output (HP:0012590) | 3.30029497 |
| 49 | Glomerulonephritis (HP:0000099) | 3.27351059 |
| 50 | Complement deficiency (HP:0004431) | 3.27020621 |
| 51 | Keratoconjunctivitis (HP:0001096) | 3.25995197 |
| 52 | Joint hemorrhage (HP:0005261) | 3.25774825 |
| 53 | Hydroxyprolinuria (HP:0003080) | 3.22785473 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 3.22785473 |
| 55 | Purpura (HP:0000979) | 3.20710677 |
| 56 | Hypolipoproteinemia (HP:0010981) | 3.20503531 |
| 57 | Delayed CNS myelination (HP:0002188) | 3.20455563 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 3.19388028 |
| 59 | Polyuria (HP:0000103) | 3.16454473 |
| 60 | Epidermoid cyst (HP:0200040) | 3.14015644 |
| 61 | Abnormality of renal excretion (HP:0011036) | 3.12295849 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.11384827 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 3.11384827 |
| 64 | Vasculitis (HP:0002633) | 3.10609160 |
| 65 | Recurrent skin infections (HP:0001581) | 3.10555430 |
| 66 | Vascular calcification (HP:0004934) | 3.10449650 |
| 67 | Glycosuria (HP:0003076) | 3.06896698 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 3.06896698 |
| 69 | Fat malabsorption (HP:0002630) | 3.06396226 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04708645 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04708645 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04708645 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04559387 |
| 74 | Amyloidosis (HP:0011034) | 3.00803836 |
| 75 | * Metabolic acidosis (HP:0001942) | 3.00564695 |
| 76 | Gangrene (HP:0100758) | 3.00286638 |
| 77 | Gingivitis (HP:0000230) | 2.99521025 |
| 78 | Obstructive lung disease (HP:0006536) | 2.97068255 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.97068255 |
| 80 | Arterial thrombosis (HP:0004420) | 2.94443671 |
| 81 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93416993 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.90313156 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.90085774 |
| 84 | Abnormality of methionine metabolism (HP:0010901) | 2.88330811 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.88014026 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.85987681 |
| 87 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84871047 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.82353072 |
| 89 | Peritonitis (HP:0002586) | 2.82209691 |
| 90 | Acanthocytosis (HP:0001927) | 2.81913442 |
| 91 | Abnormality of magnesium homeostasis (HP:0004921) | 2.80919826 |
| 92 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79850982 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 2.78527144 |
| 94 | Epistaxis (HP:0000421) | 2.76791601 |
| 95 | Episodic fever (HP:0001954) | 2.75692326 |
| 96 | Conjugated hyperbilirubinemia (HP:0002908) | 2.74025212 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.72578335 |
| 98 | * Lethargy (HP:0001254) | 2.71435557 |
| 99 | Encephalitis (HP:0002383) | 2.69888759 |
| 100 | Pulmonary embolism (HP:0002204) | 2.69716659 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.66996231 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 2.64117709 |
| 103 | Hemoptysis (HP:0002105) | 2.64038811 |
| 104 | Malnutrition (HP:0004395) | 2.63689280 |
| 105 | Meningitis (HP:0001287) | 2.58717173 |
| 106 | Renal tubular acidosis (HP:0001947) | 2.58277132 |
| 107 | Urticaria (HP:0001025) | 2.56707094 |
| 108 | Tetany (HP:0001281) | 2.56593765 |
| 109 | * Vomiting (HP:0002013) | 2.55186129 |
| 110 | Spontaneous hematomas (HP:0007420) | 2.52627362 |
| 111 | Anorexia (HP:0002039) | 2.52077674 |
| 112 | Hypercholesterolemia (HP:0003124) | 2.49966415 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 2.49388226 |
| 114 | Abnormality of T cell number (HP:0011839) | 2.45972232 |
| 115 | Disinhibition (HP:0000734) | 2.45827468 |
| 116 | Loss of speech (HP:0002371) | 2.45458865 |
| 117 | Menorrhagia (HP:0000132) | 2.44894047 |
| 118 | Joint swelling (HP:0001386) | 2.44864405 |
| 119 | Hyperbilirubinemia (HP:0002904) | 2.44623421 |
| 120 | Enlarged kidneys (HP:0000105) | 2.41976887 |
| 121 | Dysostosis multiplex (HP:0000943) | 2.40203304 |
| 122 | Nausea (HP:0002018) | 2.39625753 |
| 123 | Rickets (HP:0002748) | 2.39394501 |
| 124 | Thrombophlebitis (HP:0004418) | 2.39289757 |
| 125 | Abnormal drinking behavior (HP:0030082) | 2.39228090 |
| 126 | Polydipsia (HP:0001959) | 2.39228090 |
| 127 | Hyperaldosteronism (HP:0000859) | 2.37778684 |
| 128 | Irritability (HP:0000737) | 2.36608544 |
| 129 | Increased IgM level (HP:0003496) | 2.36429502 |
| 130 | Abnormality of the peritoneum (HP:0002585) | 2.36213054 |
| 131 | T lymphocytopenia (HP:0005403) | 2.35564460 |
| 132 | Confusion (HP:0001289) | 2.34584028 |
| 133 | Petechiae (HP:0000967) | 2.33888647 |
| 134 | Hyperphosphaturia (HP:0003109) | 2.33128625 |
| 135 | Cerebral edema (HP:0002181) | 2.31840376 |
| 136 | Sensorimotor neuropathy (HP:0007141) | 2.30951092 |
| 137 | Nephrolithiasis (HP:0000787) | 2.30523013 |
| 138 | Renal salt wasting (HP:0000127) | 2.30288434 |
| 139 | Abnormality of complement system (HP:0005339) | 2.29248112 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 2.28417204 |
| 141 | Abnormality of renin-angiotensin system (HP:0000847) | 2.27597007 |
| 142 | Abnormality of the pleura (HP:0002103) | 2.26292171 |
| 143 | Chronic diarrhea (HP:0002028) | 2.25123437 |
| 144 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24831129 |
| 145 | Spastic diplegia (HP:0001264) | 2.24025064 |
| 146 | Metaphyseal irregularity (HP:0003025) | 2.23637879 |
| 147 | Increased serum ferritin (HP:0003281) | 2.23425118 |
| 148 | Systemic lupus erythematosus (HP:0002725) | 2.22077516 |
| 149 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20484397 |
| 150 | Steatorrhea (HP:0002570) | 2.18593762 |
| 151 | Glomerulopathy (HP:0100820) | 2.18502877 |
| 152 | Hemorrhage of the eye (HP:0011885) | 2.16445149 |
| 153 | Pancreatitis (HP:0001733) | 2.15545605 |
| 154 | Chest pain (HP:0100749) | 2.12539477 |
| 155 | Neonatal onset (HP:0003623) | 2.12041047 |
| 156 | Leukocytosis (HP:0001974) | 2.12014257 |
| 157 | Widely patent fontanelles and sutures (HP:0004492) | 2.11588508 |
| 158 | Abnormal urine phosphate concentration (HP:0012599) | 2.11507105 |
| 159 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09825192 |
| 160 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09825192 |
| 161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09825192 |
| 162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09744423 |
| 163 | Hypophosphatemia (HP:0002148) | 2.09411752 |
| 164 | Mucopolysacchariduria (HP:0008155) | 2.07772302 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07772302 |
| 166 | Recurrent viral infections (HP:0004429) | 2.07379968 |
| 167 | Polyneuropathy (HP:0001271) | 2.05983508 |
| 168 | Increased IgE level (HP:0003212) | 2.05268759 |
| 169 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04854729 |
| 170 | Myocardial infarction (HP:0001658) | 2.04816791 |
| 171 | Abnormality of iron homeostasis (HP:0011031) | 2.03082277 |
| 172 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02607519 |
| 173 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00776060 |
| 174 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00776060 |
| 175 | Autoimmune hemolytic anemia (HP:0001890) | 2.00417577 |
| 176 | Nephritis (HP:0000123) | 1.93051758 |
| 177 | Spontaneous abortion (HP:0005268) | 1.90880777 |
| 178 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90752280 |
| 179 | Late onset (HP:0003584) | 1.88775698 |
| 180 | Skin nodule (HP:0200036) | 1.88680618 |
| 181 | Facial shape deformation (HP:0011334) | 1.88657981 |
| 182 | Potter facies (HP:0002009) | 1.88657981 |
| 183 | Methylmalonic aciduria (HP:0012120) | 1.88596660 |
| 184 | Acute hepatic failure (HP:0006554) | 1.85706359 |
| 185 | Acne (HP:0001061) | 1.84965867 |
| 186 | Cellulitis (HP:0100658) | 1.83983840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 5.84297455 |
| 2 | BCKDK | 5.54324394 |
| 3 | WNK4 | 4.88846694 |
| 4 | OXSR1 | 4.85994302 |
| 5 | IRAK4 | 2.87671306 |
| 6 | BLK | 2.86814664 |
| 7 | ERN1 | 2.57714882 |
| 8 | SIK1 | 2.53117429 |
| 9 | FGFR4 | 2.52720532 |
| 10 | ACVR1B | 2.45744480 |
| 11 | MST1R | 2.44715744 |
| 12 | FGR | 2.39285926 |
| 13 | MAP4K1 | 2.22817852 |
| 14 | STK38L | 2.19221671 |
| 15 | ERBB4 | 2.04968515 |
| 16 | PDK3 | 1.93833870 |
| 17 | PDK4 | 1.93833870 |
| 18 | ZAP70 | 1.90880052 |
| 19 | STK39 | 1.86457711 |
| 20 | JAK3 | 1.86116784 |
| 21 | TXK | 1.82988048 |
| 22 | IRAK1 | 1.76228477 |
| 23 | INSRR | 1.71405403 |
| 24 | NEK1 | 1.68623441 |
| 25 | TAOK1 | 1.66968929 |
| 26 | BMPR2 | 1.65288743 |
| 27 | FRK | 1.61857878 |
| 28 | TAOK3 | 1.42041422 |
| 29 | MAP3K14 | 1.41260453 |
| 30 | SYK | 1.40634289 |
| 31 | PDK2 | 1.40482701 |
| 32 | MAP3K1 | 1.37652577 |
| 33 | IKBKB | 1.37549013 |
| 34 | SGK223 | 1.33642813 |
| 35 | SGK494 | 1.33642813 |
| 36 | LATS1 | 1.30354585 |
| 37 | LYN | 1.30286257 |
| 38 | MAP2K4 | 1.29836846 |
| 39 | IRAK3 | 1.28699815 |
| 40 | MAPK11 | 1.27299366 |
| 41 | PRKAA2 | 1.26972227 |
| 42 | EPHA3 | 1.22929943 |
| 43 | DDR2 | 1.22238567 |
| 44 | GRK7 | 1.21680945 |
| 45 | GRK6 | 1.21214710 |
| 46 | STK24 | 1.20731345 |
| 47 | HCK | 1.20467520 |
| 48 | ABL2 | 1.19584609 |
| 49 | SGK2 | 1.18337174 |
| 50 | IRAK2 | 1.18006773 |
| 51 | TRIB3 | 1.15847246 |
| 52 | SGK3 | 1.15552967 |
| 53 | PINK1 | 1.13808019 |
| 54 | YES1 | 1.10413802 |
| 55 | BTK | 1.09080726 |
| 56 | MST4 | 1.08724729 |
| 57 | CDC42BPA | 1.08261019 |
| 58 | TYK2 | 1.07573328 |
| 59 | PRPF4B | 1.05451030 |
| 60 | RIPK1 | 1.04506317 |
| 61 | CAMK1D | 1.02271901 |
| 62 | NEK9 | 1.01471654 |
| 63 | MAP3K13 | 1.01434648 |
| 64 | PKN2 | 1.01407303 |
| 65 | PTK6 | 0.99532598 |
| 66 | FES | 0.98860672 |
| 67 | CSF1R | 0.96262438 |
| 68 | MAP3K3 | 0.96042361 |
| 69 | TBK1 | 0.95972983 |
| 70 | MAP3K7 | 0.91490880 |
| 71 | LCK | 0.90506357 |
| 72 | JAK2 | 0.88378249 |
| 73 | EPHB1 | 0.83996659 |
| 74 | PRKAA1 | 0.81037989 |
| 75 | DAPK2 | 0.79903315 |
| 76 | MAP2K3 | 0.78236466 |
| 77 | PDPK1 | 0.77868376 |
| 78 | MET | 0.77303685 |
| 79 | STK38 | 0.75714069 |
| 80 | GSK3A | 0.73029094 |
| 81 | SIK3 | 0.72978169 |
| 82 | PIK3CG | 0.72719464 |
| 83 | TIE1 | 0.71216192 |
| 84 | ITK | 0.70384495 |
| 85 | MARK3 | 0.69836462 |
| 86 | NLK | 0.69798368 |
| 87 | CHUK | 0.69125256 |
| 88 | FLT3 | 0.68419593 |
| 89 | JAK1 | 0.64350227 |
| 90 | MAP3K11 | 0.63242350 |
| 91 | MAPK12 | 0.62107365 |
| 92 | CAMK1G | 0.61516464 |
| 93 | PRKCZ | 0.61196406 |
| 94 | TEC | 0.60988349 |
| 95 | PRKACG | 0.57024288 |
| 96 | WNK1 | 0.56958362 |
| 97 | EPHA4 | 0.55360000 |
| 98 | MAP3K5 | 0.54095654 |
| 99 | ADRBK2 | 0.53629712 |
| 100 | RIPK4 | 0.53156903 |
| 101 | BMX | 0.52786546 |
| 102 | PIM1 | 0.52289906 |
| 103 | RET | 0.52239851 |
| 104 | TNK2 | 0.50943657 |
| 105 | PDK1 | 0.49646794 |
| 106 | TGFBR2 | 0.48633740 |
| 107 | MAPK4 | 0.47886254 |
| 108 | FYN | 0.47221486 |
| 109 | IKBKE | 0.46375950 |
| 110 | MAP2K1 | 0.45075469 |
| 111 | MAP3K6 | 0.44491550 |
| 112 | CSK | 0.43668920 |
| 113 | PTK2 | 0.41926254 |
| 114 | ERBB2 | 0.40829461 |
| 115 | SGK1 | 0.40627514 |
| 116 | PBK | 0.37960732 |
| 117 | TAOK2 | 0.37430862 |
| 118 | MYLK | 0.37095610 |
| 119 | AKT3 | 0.36093469 |
| 120 | KSR2 | 0.35992552 |
| 121 | MAPKAPK2 | 0.35836331 |
| 122 | PDGFRB | 0.35510881 |
| 123 | STK3 | 0.35377103 |
| 124 | DYRK3 | 0.35193830 |
| 125 | MAP2K6 | 0.33486776 |
| 126 | KIT | 0.33275616 |
| 127 | ALK | 0.33026109 |
| 128 | PRKG2 | 0.32474157 |
| 129 | PRKCD | 0.32363568 |
| 130 | PRKCQ | 0.31826261 |
| 131 | LRRK2 | 0.31716720 |
| 132 | MARK2 | 0.31645146 |
| 133 | CDK6 | 0.30874526 |
| 134 | IGF1R | 0.30638967 |
| 135 | CAMK2G | 0.30567235 |
| 136 | PDGFRA | 0.30236880 |
| 137 | GRK1 | 0.29221700 |
| 138 | TYRO3 | 0.29103100 |
| 139 | PRKCA | 0.28401889 |
| 140 | KDR | 0.27242390 |
| 141 | STK10 | 0.26463671 |
| 142 | MAP3K12 | 0.26313992 |
| 143 | HIPK2 | 0.26186125 |
| 144 | KSR1 | 0.25667786 |
| 145 | PIK3CA | 0.24968999 |
| 146 | MAP3K2 | 0.24938436 |
| 147 | EGFR | 0.24873052 |
| 148 | LMTK2 | 0.23572094 |
| 149 | FGFR3 | 0.22067516 |
| 150 | DYRK1B | 0.18556321 |
| 151 | MATK | 0.18541837 |
| 152 | ABL1 | 0.18465842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32513693 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23268478 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.07239240 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.93869918 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.85940356 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83969057 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81039880 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77793233 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.72309236 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.68504578 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62415436 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61407997 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48805168 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48569124 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46034980 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.38350698 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32521615 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26434289 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23223758 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20711389 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18185545 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08949358 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02031539 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 2.01516558 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 2.01242991 |
| 26 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95457339 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.94380284 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93977287 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92718860 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.91651608 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.90774491 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.89897944 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82027413 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79374780 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76961373 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.73268895 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72838865 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.70002349 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65399687 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.65041523 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62978478 |
| 42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62357886 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62108592 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57659244 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55919621 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55419254 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.54514717 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53743200 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53244012 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53187325 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51073949 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48923107 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.46846347 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46161842 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44971315 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40603559 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40283527 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39339933 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37390930 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37281785 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37084003 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.34850445 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33549214 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33244403 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32230640 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30253773 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29129067 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28367639 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27540723 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25262130 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25090717 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 1.21728367 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20612063 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20026517 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19701482 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19248420 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17736646 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14920838 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 1.13408115 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10214142 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10118490 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09183399 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07791981 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06683263 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04521619 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04208841 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.99768712 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98790362 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.96191173 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93358149 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.92420016 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87717902 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86482421 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85325565 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81939163 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80710250 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80643248 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79055989 |
| 99 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78852548 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76977617 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75985202 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.75344754 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.72774865 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72602650 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72167204 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71539018 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.71222588 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69202750 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.68510814 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65905401 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63304472 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63158459 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62072397 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60976535 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60029116 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59591514 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.58582133 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57223949 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55309711 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52633032 |
| 121 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49992197 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46947093 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46352645 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45918014 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45061689 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44293915 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40978005 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39941972 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37994807 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.37551324 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37548839 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36053241 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31363497 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30624164 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29351560 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25775883 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23944014 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.23557261 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22056950 |
| 140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14561273 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11865771 |
| 142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10293057 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.09761636 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.07656728 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07613652 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05379162 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03983732 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03422328 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.03198866 |
| 150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02140658 |
| 151 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01495391 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01381208 |
| 153 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1419970 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1394349 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1378480 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1345533 |
| 157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1266764 |
| 158 | Hepatitis C_Homo sapiens_hsa05160 | -0.0545593 |
| 159 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0286707 |
| 160 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0206715 |
| 161 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0176980 |

